Correction to: Clinical and Translational Oncology https://doi.org/10.1007/s12094-019-02166-z
Acknowledgements section was missing in the original published version. The Acknowledgement section read as follows:
Acknowledgements
FB supported by AIRC IG 20109.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Passaro, A., Mancuso, P., Gandini, S. et al. Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy. Clin Transl Oncol 22, 621 (2020). https://doi.org/10.1007/s12094-019-02198-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-019-02198-5